Targeted Potassium Levels for Prevention of ICD Therapy
NCT03833089 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1200
Last updated 2025-05-09
Summary
This study evaluates whether a rigorously controlled high-normal level of serum-potassium (4.5-5.0 mEq/L) using dietary recommendations, potassium supplements and mineralocorticoid receptor antagonists will results in a lower incidence of cardiac arrhythmias in patients with an ICD. Patients will be randomized to this treatment or a control arm, where patients will receive usual guideline recommended follow-up.
Conditions
- Ventricular Arrhythmias and Cardiac Arrest
- Implantable Defibrillator User
- Hypokalemia
- Hyperkalemia
- Ventricular Tachycardia
- Atrial Fibrillation
Interventions
- COMBINATION_PRODUCT
-
Targeted serum potassium level
In the following order, following advices end prescriptions will be provided: 1) Potassium rich dietary advice, 2) Mineralocorticoid receptor antagonists, 3) Potassium supplementation,
Sponsors & Collaborators
-
Herlev and Gentofte Hospital
collaborator OTHER -
Rigshospitalet, Denmark
lead OTHER
Principal Investigators
-
Christian Joens, MD, PhD · Dept of Cardiology, Rigshospitalet, Denmark
-
Niels Risum, MD, PhD · Dept of Cardiology, Rigshospitalet, Denmark
-
Henning Bundgaard, Prof., DMSc · Dept of Cardiology, Rigshospitalet, Denmark
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2025-05-09
- Completion
- 2035-04-01
Countries
- Denmark
Study Locations
More Related Trials
-
Exploring Mechanisms and Morphology of QT Interval Prolongation
NCT03291145 ·Status: COMPLETED ·Phase: NA
-
Proarrhythmic Medicines and Primary Cardiac Arrest
NCT00005253 ·Status: COMPLETED
-
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
NCT01557842 ·Status: TERMINATED ·Phase: PHASE4
-
A Study to Detect Hyperkalemia Using Smartphone-enabled Electrocardiogram (EKG)
NCT05441852 ·Status: COMPLETED
-
Prevention of Atrial Fibrillation by Optimized Overdrive Stimulation
NCT01912326 ·Status: COMPLETED ·Phase: NA
-
To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients
NCT01665755 ·Status: COMPLETED ·Phase: NA
-
Substrate Modification in Stable Ventricular Tachycardia in Addition to Implantable Cardioverter Defibrillator (ICD) Therapy
NCT00919373 ·Status: COMPLETED ·Phase: NA
-
END - VT Cohort Study
NCT05835791 ·Status: RECRUITING
-
Primary Preventive Ventricular Tachycardia Ablation In High-Risk Patients Who Receive A Prophylactic Implantable Cardioverter Defibrillator
NCT06543173 ·Status: RECRUITING ·Phase: NA
-
Role of the Wearable Cardioverter Defibrillator in Tachycardia Induced Cardiomyopathy
NCT03388905 ·Status: UNKNOWN ·Phase: NA
-
Proton Particle Therapy for Cardiac Arrhythmia
NCT04392193 ·Status: COMPLETED ·Phase: NA
-
Ablation at Virtual-hEart pRedicted Targets for VT
NCT03536052 ·Status: COMPLETED ·Phase: NA
-
Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
NCT03640949 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prevention of Atrial Tachycardia After a Right Atriotomy II
NCT00709384 ·Status: COMPLETED ·Phase: PHASE2
-
Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias
NCT02837328 ·Status: COMPLETED ·Phase: PHASE2
-
An Arrhythmia Risk Stratification and Genetic Trial
NCT01209494 ·Status: COMPLETED
-
The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock
NCT00787800 ·Status: COMPLETED ·Phase: PHASE4
-
Transcutaneous Vagal Nerve Stimulation to Prevent Tachyarrhythmias in Patients Early Following Myocardial Infarction
NCT05750108 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Arrhythmias at Extreme Altitude
NCT05676398 ·Status: UNKNOWN
-
Potassium Chloride in Out-of-hospital Cardiac Arrest Due to Refractory Ventricular Fibrillation
NCT04316611 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
NCT01013714 ·Status: RECRUITING ·Phase: PHASE3
-
Long Term Monitoring for Risk of Sudden Death
NCT04124237 ·Status: COMPLETED
-
Prospective Evaluation Analysis and Kinetics Registry
NCT05247320 ·Status: COMPLETED
-
ATrial Tachycardia PAcing Therapy in Congenital Heart
NCT03209583 ·Status: RECRUITING
-
Prognostic Significance of T Wave Alternans
NCT00006501 ·Status: COMPLETED